Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ultraviolet A Radiation (UVA II)
- Molecular classification
- Electromagnetic Radiation
01
Overview
Ultraviolet A Radiation (UVA II) is a form of electromagnetic radiation with wavelengths between 320 and 340 nanometers. It penetrates deeply into the skin, causing oxidative DNA damage, collagen breakdown, apoptosis, and inflammation. Chronic exposure contributes to photoaging and increases the risk of skin cancer.
- Other names
- UVA II320-340 nm Ultraviolet Radiation
02
Biological functions
Induction of oxidative stressDNA damageCollagen breakdownApoptosis inductionInflammation
03
Disease associations
PhotoagingSkin cancer
04
Safety considerations
Increased risk of skin cancerPremature skin aging
05
Interacting drugs
Sunscreens (broad spectrum)
Beyond the preview
Go deeper on Ultraviolet A Radiation (UVA II).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ultraviolet A Radiation (UVA II).